IMPROVE: a feature model to predict neoepitope immunogenicity through broad-scale validation of T-cell recognition
BackgroundMutation-derived neoantigens are critical targets for tumor rejection in cancer immunotherapy, and better tools for neoepitope identification and prediction are needed to improve neoepitope targeting strategies. Computational tools have enabl…